These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Oncogenic E17K mutation in the pleckstrin homology domain of AKT1 promotes v-Abl-mediated pre-B-cell transformation and survival of Pim-deficient cells. Guo G; Qiu X; Wang S; Chen Y; Rothman PB; Wang Z; Chen Y; Wang G; Chen JL Oncogene; 2010 Jul; 29(26):3845-53. PubMed ID: 20440266 [TBL] [Abstract][Full Text] [Related]
11. Constitutively active Akt1 cooperates with KRas(G12D) to accelerate in vivo pancreatic tumor onset and progression. Albury TM; Pandey V; Gitto SB; Dominguez L; Spinel LP; Talarchek J; Klein-Szanto AJ; Testa JR; Altomare DA Neoplasia; 2015 Feb; 17(2):175-82. PubMed ID: 25748236 [TBL] [Abstract][Full Text] [Related]
12. Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung. Malanga D; Scrima M; De Marco C; Fabiani F; De Rosa N; De Gisi S; Malara N; Savino R; Rocco G; Chiappetta G; Franco R; Tirino V; Pirozzi G; Viglietto G Cell Cycle; 2008 Mar; 7(5):665-9. PubMed ID: 18256540 [TBL] [Abstract][Full Text] [Related]
13. Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro. Chung HW; Wen J; Lim JB; Bang S; Park SW; Song SY Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):862-9. PubMed ID: 19801102 [TBL] [Abstract][Full Text] [Related]
14. Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas. Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shiratori K; Kawamura S; Kobayashi M; Shimizu M; Ban S; Koyama I; Higashi M; Shin N; Ishida K; Morikawa T; Motoi F; Unno M; Kanno A; Satoh K; Shimosegawa T; Orikasa H; Watanabe T; Nishimura K; Harada Y; Furukawa T Am J Surg Pathol; 2011 Dec; 35(12):1812-7. PubMed ID: 21945955 [TBL] [Abstract][Full Text] [Related]
15. PI3K/Akt pathway mutations in retinoblastoma. Cohen Y; Merhavi-Shoham E; Avraham-Lubin BC; Savetsky M; Frenkel S; Pe'er J; Goldenberg-Cohen N Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5054-6. PubMed ID: 19420344 [TBL] [Abstract][Full Text] [Related]
16. AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K. Askham JM; Platt F; Chambers PA; Snowden H; Taylor CF; Knowles MA Oncogene; 2010 Jan; 29(1):150-5. PubMed ID: 19802009 [TBL] [Abstract][Full Text] [Related]
17. Mutant AKT1-E17K is oncogenic in lung epithelial cells. De Marco C; Malanga D; Rinaldo N; De Vita F; Scrima M; Lovisa S; Fabris L; Carriero MV; Franco R; Rizzuto A; Baldassarre G; Viglietto G Oncotarget; 2015 Nov; 6(37):39634-50. PubMed ID: 26053093 [TBL] [Abstract][Full Text] [Related]
18. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Veit C; Genze F; Menke A; Hoeffert S; Gress TM; Gierschik P; Giehl K Cancer Res; 2004 Aug; 64(15):5291-300. PubMed ID: 15289335 [TBL] [Abstract][Full Text] [Related]
19. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Carpten JD; Faber AL; Horn C; Donoho GP; Briggs SL; Robbins CM; Hostetter G; Boguslawski S; Moses TY; Savage S; Uhlik M; Lin A; Du J; Qian YW; Zeckner DJ; Tucker-Kellogg G; Touchman J; Patel K; Mousses S; Bittner M; Schevitz R; Lai MH; Blanchard KL; Thomas JE Nature; 2007 Jul; 448(7152):439-44. PubMed ID: 17611497 [TBL] [Abstract][Full Text] [Related]